Imed Infinity Shares Owned By Insiders vs. Beta

IMED Stock   104.50  5.80  5.26%   
Based on the key profitability measurements obtained from Imed Infinity's financial statements, Imed Infinity Medical Limited may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Imed Infinity's ability to earn profits and add value for shareholders.
For Imed Infinity profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Imed Infinity to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Imed Infinity Medical Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Imed Infinity's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Imed Infinity Medical Limited over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Imed Infinity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Imed Infinity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Imed Infinity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Imed Infinity Medical Beta vs. Shares Owned By Insiders Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Imed Infinity's current stock value. Our valuation model uses many indicators to compare Imed Infinity value to that of its competitors to determine the firm's financial worth.
Imed Infinity Medical Limited is currently regarded as number one stock in shares owned by insiders category among its peers. It also is currently regarded as number one stock in beta category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Imed Infinity by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Imed Infinity's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Imed Beta vs. Shares Owned By Insiders

Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Imed Infinity

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
20.90 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Imed Infinity

Beta

 = 

Covariance

Variance

 = 
-0.13
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

Imed Beta Comparison

Imed Infinity is currently under evaluation in beta category among its peers.

Beta Analysis

As returns on the market increase, returns on owning Imed Infinity are expected to decrease at a much lower rate. During the bear market, Imed Infinity is likely to outperform the market.

Imed Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Imed Infinity. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Imed Infinity position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Imed Infinity's important profitability drivers and their relationship over time.

Use Imed Infinity in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Imed Infinity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imed Infinity will appreciate offsetting losses from the drop in the long position's value.

Imed Infinity Pair Trading

Imed Infinity Medical Limited Pair Trading Analysis

The ability to find closely correlated positions to Imed Infinity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Imed Infinity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Imed Infinity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Imed Infinity Medical Limited to buy it.
The correlation of Imed Infinity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Imed Infinity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Imed Infinity Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Imed Infinity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Imed Infinity position

In addition to having Imed Infinity in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Plastics Thematic Idea Now

Plastics
Plastics Theme
Companies manufacturing rubber and plastics accessories. The Plastics theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Imed Stock

To fully project Imed Infinity's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Imed Infinity Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Imed Infinity's income statement, its balance sheet, and the statement of cash flows.
Potential Imed Infinity investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Imed Infinity investors may work on each financial statement separately, they are all related. The changes in Imed Infinity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Imed Infinity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.